Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ACC/AHA 2018 Cholesterol Guideline: The New and the Old Drs Michael Blaha and Salim Virani review key takeaways from the 2018 ACC/AHA updated cholesterol guideline, noting that much is new in management of patients with elevated lipids.
American College of Cardiology & Medscape , November 16, 2018
First-Ever Pediatric Concussion Guidelines: Real-Life CasesAre you up on the new guidelines for evaluating kids with possible mild traumatic brain injury? These cases illustrate key points to be aware of, wherever you encounter these children.
Should You Opt Out of Medicare? Pros and ConsMany physicians are fed up with Medicare's rules, reimbursement, and reporting requirements. But before letting your patient panel go, consider the possible benefits and risks.
Medscape Business of Medicine, November 2018
Lawsuit if You Don't Disclose Your Lack of Expertise?It's hard to become expert on a procedure if you don't keep getting experience, but must you tell your patient how many (or few) of the procedures you have done?
Smart End-of-Year Tax Tips: 2018Most people put off thinking about taxes for as long as possible. But by following a few simple strategies before the end of the year, you can save a bundle come next April.
Can Patient-Generated Data Help Regulate Medical Devices?An FDA panel discussed ways the agency can use patient-driven platforms -- including social media, digital health technology, and patient registry data -- to assist with regulatory evaluation of medical devices.
Medscape Medical News, November 16, 2018
AHA 2018Biodegradable Polymer Stent No Better Than Xience at 10 Years Both drug-eluting stents showed reduced outcomes, including mortality, compared with an early device, but no difference between the stents at 10-year follow-up of the ISAR-TEST 4 trial.
Medscape Medical News, November 16, 2018
AlertApproval in 2 Weeks via FDA's New Oncology Drugs ReviewApproval of a new indication took only 2 weeks with the FDA's new program for reviewing oncology drugs. It involved expanded use of the lymphoma drug brentuximab vedotin.
CV Risk Assessment: A Process, Not a Calculation Tips on how to estimate, personalize, and reclassify patient risk in light of the new cholesterol guidelines. Dr Blaha walks through a typical patient case with guideline writer Dr Lloyd-Jones
American College of Cardiology & Medscape , November 16, 2018
